HomeAI · summaries
Storia in 3 fonti
In Washington, biotech's China hawks are winning the conversation
PhRMA and BIO mobilize against a wave of anti-China biotech bills in Congress as lawmakers move to curb US dealmaking with China.
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
biopharmadive.com
House bill aims to crack down on China biotech deals
A proposal to add biotechnology to the COINS Act follows two big deals involving Pfizer and Bristol Myers, and comes amid U.S. fears that China’s drugmaking progress may threaten…
- ·
fiercebiotech.com
As China biotech crackdown calls reverberate in Washington, the pushback gets louder, too
Two federal lawmakers have introduced a bill seeking to apply the review requi | Two federal lawmakers have introduced a bill seeking to apply the review requirements of the…
